Celebrating our 29th year of research and improved outcomes.

MAT® PHYSIOLOGY

MAT®treatment (metabolic activation therapy) involves delivering insulin intravenously in a pulsatile fashion using a special pump over a six to seven hour period.

Pumps used in the MAT® treatment procedure are not the typical insulin pumps in common use for diabetes. The usual insulin pump delivers insulin subcutaneously. Several FDA approved pumps for intravenous use can be used for MAT® treatment.

The pulses deliver a higher, more physiologic concentration of insulin to the liver than are delivered by traditional sub-cutaneous injections. This higher level of insulin available to the liver with metabolic activation therapy stimulates liver cells to synthesize glucokinase and other insulin-dependent enzymes necessary for normal dietary glucose processing and homeostasis.

Liver

In “normal” individuals(without diabetes), insulin levels measured in the portal vein to the liver can range from 200 microU/ml* to 1,000 microU/ml immediately following a meal. Unfortunately, the insulin levels of type I diabetes patients on standard subcutaneous insulin therapy only reach a concentration of 15 microU/ml to 20 microU/ml at the portal vein. These lower insulin levels are insufficient to activate and maintain optimal hepatic glucose processing.

In contrast to usual insulin therapy, MAT® treatment pulses appear to enhance the liver’s ability to store, mobilize and utilize glucose. The higher level of insulin available to the liver with MAT® treatment stimulates liver cells to synthesize glucokinase and other insulin-dependent enzymes necessary for normal dietary glucose processing and homeostasis.

In Type 1 diabetes

MAT® treatment

Conventional Insulin Therapy

Insulin injection site

Directly into a vein

Subcutaneous tissue

Pattern of insulin delivery to the liver

Rapidly

Pulses – sharp spikes

Slowly

Gradual rise and fall

Level of insulin available to the liver.

Very High

(200-1000 microU/ml)*

Very Low

(15-20 microU/ml)*

* microU /ml = one millionth of a Unit of insulin per milliliter

Other Tissues

At times of reduced tissue oxygen, such as when circulation is decreased, MAT® treatment (by enabling the production of energy from glucose) may permit heart, skeletal muscle, skin, and other organs to function more normally and even to repair damage and heal.

Because the insulin pulses are “seen” by the entire body, not just the liver, the pulses may alter and improve the metabolism of other organs besides the liver. In both normal and diabetic individuals, most organs rely on the metabolism of fatty acids for 70 percent to 80 percent of their fuel. However, the breakdown of fatty acids requires more oxygen at the cellular level than the breakdown of glucose for a given energy output. Pulsed insulin therapy may permit organs to use glucose as an energy source to a significantly greater extent than usual (due to increased pyruvate dehydrogenase activity) and thus decrease the organ’s oxygen requirements.